| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
PEX19 serves as a critical cytosolic chaperone and import receptor essential for peroxisomal membrane protein biogenesis. This farnesylated protein recognizes and binds newly synthesized peroxisomal membrane proteins in the cytoplasm, guiding them to the peroxisomal membrane for proper insertion. Mutations in PEX19 are associated with Zellweger syndrome spectrum disorders, making this target particularly relevant for researchers investigating peroxisome biogenesis disorders, metabolic disease mechanisms, and organelle assembly pathways.
This recombinant monoclonal antibody, clone 8C2, offers the reproducibility and consistency that demanding experimental workflows require. Developed using recombinant technology with a defined sequence, this rabbit IgG eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations. The antibody was raised against a synthesized peptide derived from human PEX19 protein and purified by affinity chromatography, ensuring high specificity for your target.
Validation in immunohistochemistry demonstrates reliable performance in formalin-fixed, paraffin-embedded human tissues. Testing in human liver cancer tissue sections using a Leica Bond system with citrate buffer antigen retrieval and HRP-polymer detection produced clear staining at 1:100 dilution, with recommended working concentrations ranging from 1:50 to 1:200 depending on your specific tissue and detection system. The antibody is also validated for ELISA applications, providing flexibility across different experimental platforms.
Whether you are investigating peroxisome assembly mechanisms, characterizing patient-derived samples for peroxisomal disorders, or studying the broader landscape of organelle biogenesis, this PEX19 antibody delivers the specificity and batch consistency needed for confident, reproducible results in your research.
Email: support@cusabio.com
Distributors Worldwide